Dr. Reddy’s Laboratories Ltd. ADR (NYSE: RDY) is 0.13% higher on its value in year-to-date trading and has touched a low of $13.43 and a high of $16.89 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The RDY stock was last observed hovering at around $15.67 in the last trading session, with the day’s gains setting it 0.14%.
Currently trading at $15.81, the stock is 4.03% and 6.74% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.25 million and changing 0.89% at the moment leaves the stock 4.33% off its SMA200. RDY registered 13.15% gain for a year compared to 6-month loss of 1.06%. The firm has a 50-day simple moving average (SMA 50) of $14.81224 and a 200-day simple moving average (SMA200) of $15.15369.
The stock witnessed a 8.51% gain in the last 1 month and extending the period to 3 months gives it a 0.38%, and is 0.13% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.27% over the week and 1.29% over the month.
Dr. Reddy’s Laboratories Ltd. ADR (RDY) has around 27048 employees, a market worth around $13.17B and $3.60B in sales. Current P/E ratio is 20.61 and Fwd P/E is 19.40. Profit margin for the company is 17.79%. Distance from 52-week low is 17.70% and -6.41% from its 52-week high. The company has generated returns on investments over the last 12 months (17.14%).
The EPS is expected to grow by 1.50% this year
The shares outstanding are 834.38M, and float is at 833.03M with Short Float at 1.30%.
The top institutional shareholder in the company is JPMORGAN CHASE & CO with over 0.64 million shares valued at $48.67 million. The investor’s holdings represent 1.9149 of the RDY Shares outstanding. As of 2024-06-30, the second largest holder is ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. with 2.07 million shares valued at $157.65 million to account for 1.2427 of the shares outstanding. The other top investors are ROYAL BANK OF CANADA which holds 2.06 million shares representing 1.2345 and valued at over $156.61 million, while MORGAN STANLEY holds 1.2191 of the shares totaling 2.03 million with a market value of $154.67 million.
